Clinical trial

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

NCT05684276

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-05-12

PhasePHASE2

Study timeline

Study start (actual)2023-05-12Date precision: day

Registry last updated2026-05-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

Pancoast Tumorunresolved

Interventions

CarboplatinDRUG · verified · RxNorm: carboplatin

PaclitaxelDRUG · verified · RxNorm: paclitaxel

NivolumabDRUG · verified · RxNorm: nivolumab

Sponsors & collaborators

Fundación GECPlead sponsor

Mapped research locations

MadridMadrid, Spain4 BarcelonaBarcelona, Spain4

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05684276 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.